Predictors of remission from generalized anxiety disorder and major depressive disorder

被引:34
|
作者
Kelly, Kristen M. [1 ]
Mezuk, Briana [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Richmond, VA 23284 USA
关键词
ADVERSE CHILDHOOD EXPERIENCES; WORLD-HEALTH-ORGANIZATION; REPLICATION NCS-R; MENTAL-HEALTH; PSYCHIATRIC COMORBIDITY; PANIC DISORDER; SOCIAL PHOBIA; RISK-FACTORS; RECOVERY; CHRONICITY;
D O I
10.1016/j.jad.2016.10.042
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The predictors of onset of major depressive disorder (MDD) and generalized anxiety disorder (GAD) are well-characterized. However the factors that predict remission from these conditions are less clear, and the study of this area is further complicated by differing definitions of remission. Methods: Data come from the National Comorbidity Survey - Replication, and analysis was limited to respondents with a lifetime history of GAD (n=621) or MDD (n=1299) assessed by the Composite International Diagnostic Interview. Predictors of remission included demographic factors, adverse childhood events, family history, and clinical characteristics. Multiple definitions of remission were explored to account for residual symptoms. Results: Half (54.4%) of respondents with MDD and 41.1% of respondents with GAD experienced full remission. Older age and higher socioeconomic status were positively related to remission in a dose-response manner for both disorders. Adverse childhood experiences and family history of anxious/depressive symptoms were negatively associated with remission from MDD. Comorbid GAD was inversely associated with remission from MDD (Odds ratio (OR): 0.62, 95% Confidence interval (CI): 0.44-0.88), but comorbid MDD did not impact remission from GAD (OR: 0.93, 95% CI: 0.64-1.35). With the exception of the influence of comorbidity, these associations were robust across definitions of remission. Limitations: Cross-sectional analysis and retrospective recall of onset of MDD/GAD. Conclusions: Many individuals with MDD or GAD will experience full remission. Some predictors appear to have a general association with remission from both disorders, while others are uniquely associated with remission from MDD.
引用
收藏
页码:467 / 474
页数:8
相关论文
共 50 条
  • [41] Venlafaxine in depressive disorder comorbid with generalized anxiety disorder
    Kulenovic, A. Dzubur
    Kucukalic, A.
    Bravo-Mehmedbasic, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S466 - S467
  • [42] Generalized anxiety disorder comorbidities: Panic and depressive disorder
    Turki, M.
    Ben Thabet, J.
    Charfi, N.
    Mezghanni, M.
    Bouali, M. Maalej
    Zouari, N.
    Zouari, L.
    Maalej, M.
    [J]. EUROPEAN PSYCHIATRY, 2017, 41 : S486 - S486
  • [43] Posttyphoon Prevalence of Posttraumatic Stress Disorder, Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder in a Vietnamese Sample
    Amstadter, Ananda B.
    Acierno, Ron
    Richardson, Lisa K.
    Kilpatrick, Dean G.
    Gros, Daniel F.
    Gaboury, Mario T.
    Trinh Luong Tran
    Lam Tu Trung
    Nguyen Thanh Tam
    Tran Tuan
    La Thi Buoi
    Tran Thu Ha
    Tran Duc Thach
    Galea, Sandro
    [J]. JOURNAL OF TRAUMATIC STRESS, 2009, 22 (03) : 180 - 188
  • [44] Predictors of conversion of major depressive disorder to bipolar disorder
    Suhas, Satish
    Thakurdesai, Abha
    Joseph, Amal Jolly
    Andrade, Chittaranjan
    [J]. PSYCHIATRY RESEARCH, 2021, 300
  • [45] Predictors of remission with placebo using an integrated study database from patients with major depressive disorder
    Nelson, J. C.
    Zhang, Q.
    Deberdt, W.
    Marangell, L. B.
    Karamustafalioglu, O.
    Lipkovich, I. A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 325 - 334
  • [46] EVALUATING PREDICTORS FOR REMISSION WITH PLACEBO USING INTEGRATED DATA FROM PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Deberdt, W.
    Nelson, J. C.
    Lipkovich, I. A.
    Marangell, L. B.
    Zhang, Q.
    Holsboer-Trachsler, E.
    Rihmer, Z.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [47] Psychosocial and Clinical Predictors of Symptom Persistence vs Remission in Major Depressive Disorder
    Enns, Murray W.
    Cox, Brian J.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (12): : 769 - 777
  • [48] Imaging predictors of remission to anti-depressant medications in major depressive disorder
    Chi, Kee F.
    Korgaonkar, Mayuresh
    Grieve, Stuart M.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 134 - 144
  • [49] Blood Lead Levels and Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder in US Young Adults
    Bouchard, Maryse
    Bellinger, David C.
    Weuve, Jennifer
    Matthews-Bellinger, Julia
    Gilman, Stephen
    Wright, Robert O.
    Schwartz, Joel
    Weisskopf, Marc G.
    [J]. EPIDEMIOLOGY, 2009, 20 (06) : S38 - S38
  • [50] Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?
    Merino, Hipolito
    Senra, Carmen
    Ferreiro, Fatima
    [J]. PLOS ONE, 2016, 11 (05):